Respiratory Inhalers Market Research Report- Global Forecast To 2023

Respiratory Inhalers Market Research Report- Global Forecast To 2023

ID: MRFR/HC/2237-CRR | May, 2017 | Region: Global | 111 pages | Cooked Research Reports

Respiratory Inhalers market information, by type (manually operated, digitally operated), by product (dry powder inhaler, metered dose inhaler, and others), by application (asthma, COPD, and other), by end user (hospitals & clinics, respiratory care center, and other) - Forecast to 2023


 


Respiratory Inhalers market by Type, 2016 (USD Million)


 



Market Synopsis of Respiratory Inhalers market:

Market Scenario:


Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. To counter these respiratory disorders, scientists have developed various drugs and devices. Extensive efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder which affects the majority of the patients. According to WHO, more than 300 million people in the world are affected by asthma and more than 200 million people are affected by the COPD by 2016. Globally the market for respiratory inhalers is growing steadily. Globally the market for respiratory inhaler is expected to grow at the rate of about 6.1% from 2017 to 2023.



Key Finding



  • The respiratory inhalers global market and is expected to reach $33,572.9 million by 2023.

  • Manually Operated Inhalers holds the largest share of 89.9% of the market.

  • North America holds the largest market share of respiratory Inhalers market and is anticipated to reach $11,949.4 million by the end of forecast period.

  • Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of 6.7% during the forecast period.



Segments:                                                                                                                                        

Respiratory Inhalers market has been segmented on the basis of type which comprises of manually operated, digitally operated. Manually operated inhalers accounted for the largest market share of the total market in 2016. On the basis of product, the market is segmented into dry powder inhaler, metered dose inhaler, and others. Dry powder inhalers accounted for the largest market share in 2016. On the basis of application, market is segmented into asthma, COPD, and other. Asthma segment accounted for the largest market share of the total market in 2016. On the basis of end user, market is segmented into hospitals & clinics, respiratory care center, and other. Hospitals & clinics dominated the global market with the largest market share of the total market in 2016.


 


Regional Analysis of Respiratory Inhalers Market:             


Globally North America is the largest market for Respiratory Inhalers accounting 35.1% of the total market. This large share is majorly due to, tobacco smoke which is a key factor in the development and progression of COPD. COPD was considered the third leading cause of death in U.S. in 2014, with almost 6.4% of Americans diagnosed with the disease. Currently most of the inhalers are sold in North America with very less contribution from other regions. North America market is expected to reach $11,949.4 million by 2023. Europe is the second-largest market majorly due to companies or the key players present in the region such as, Novartis, AstraZeneca, and Boehringer Ingelheim. Adoption of respiratory inhalers by hospitals and patients in the European countries, and also due to continuous efforts made by European Academy of Allergy & Clinical Immunology to increase awareness about asthma and COPD the market for respiratory inhalers is expected to show grow in the coming future. European market is expected to reach 11,425.7 by 2023.  Furthermore, Asia-Pacific market is expected to be the fastest growing market for respiratory inhalers due to continuous developments in developing countries like India and China. Emerging economies are expected to accounts for the maximum cases of respiratory disorders, remains unnoticed. Moreover, significant growth in the digitally operated inhalers is observed in the countries like Australia and New Zealand. Asia–Pacific region is expected to grow at 6.7% CAGR during the forecasted period.  On the other hand, Middle East & Africa contributed the least in the global market with only 9.2% share. Middle East & Africa regions are expected to have a limited but steady growth.



Key Players for Respiratory Inhalers Market:      
                                        


Some of the key players in this market are: Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc, Propeller Health, and Teva Pharmaceutical Industries Ltd.  
    


Intended Audience



  • Respiratory Inhaler manufacturers and suppliers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Academic Institutes and Universities



The report for
Respiratory Inhalers market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

2.1 Definition

2.2 Scope of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

2.5 Market Structure

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4.1 Introducton

4.2 Drivers

4.2.1 Rising prevalence of chronic respiratory disease

4.2.2 Increasing usage of combination therapy

4.2.3 Growing need for rescue medication

4.2.4 Technological advancements

4.3 Restraints

4.3.1 No single, effective device for every respiratory disorders

4.3.2 Side effects and complications during inhalation

4.3.3 High price

4.3.4 Non-standardized dosage

4.4 Opportunities

4.4.1 Advanced products

4.4.2 Increasing demand in developing countries

4.5 Challenges

4.5.1 Strong competition

4.5.2 More advanced products

5.1 Porter’s Five Forces Model

5.1.1 Bargaining power of suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

6.1 Introduction

6.2 Manually Operated Inhaler

6.3 Digitally Operated Inhaler

7.1 Introduction

7.2 Dry Powder Inhaler

7.3 Metered Dose Inhaler

9.1 Introduction

9.2 Hospitals & Clinics

9.3 Respiratory Care Centers

0.1 Introduction

10.2 North America

10.2.1 US

10.2.2 Canada

10.3 Europe

10.3.1 Germany

10.3.2 France

10.3.3 U.K.

10.3.4 Italy

10.3.5 Spain

10.3.6 Rest of Western Europe

10.3.7 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Republic of Korea

10.4.5 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

11 Competitive Landscape

11.1 Company Share Analysis

11.1 Company Share Analysis

12.1 Adherium

12.1.1 Company Overview

12.1.2 Product/Business Overview

12.1.3 Adherium Health: Financials

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 AstraZeneca

12.2.1 Company Overview

12.2.2 Product overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Boehringer Ingelheim GmbH

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Chiesi Farmaceutici S.p.A.

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Developments

12.4.5 SWOT Analysis

12.5 GlaxoSmithKline

12.5.1 Company Overview

12.5.2 Product overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Propeller Health

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Propeller Health: Financials

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Teva Pharmaceutical Industries Ltd

12.7.1 Company Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

TABLE 1 GLOBAL RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 2 GLOBAL MANUALLY OPERATED INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)
TABLE 3 GLOBAL DIGITALLY OPERATED INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)
TABLE 4 GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 5 GLOBAL DRY POWDER INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)
TABLE 6 GLOBAL METERED DOSE INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)
TABLE 7 GLOBAL RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 8 GLOBAL RESPIRATORY INHALER MARKET FOR ASTHMA, BY REGION, 2014-2023 (USD MILLION)
TABLE 9 GLOBAL RESPIRATORY INHALER MARKET FOR COPD, BY REGION, 2014-2023 (USD MILLION)
TABLE 10 GLOBAL RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 11 GLOBAL RESPIRATORY MARKET FOR HOSPITAL, BY REGION, 2014-2023 (USD MILLION)
TABLE 12 GLOBAL RESPIRATORY INHALER MARKET FOR RESPIRATORY CARE CENTERS, BY REGION,
2014-2023 (USD MILLION) 39
TABLE 13 GLOBAL RESPIRATORY INHALERS MARKET, BY REGION, 2014-2023 (USD MILLION)
TABLE 14 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)
TABLE 15 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 16 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 17 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 18 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 19 US RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 20 US RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 21 US RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 22 US RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 23 CANADA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 24 CANADA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 25 CANADA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 26 CANADA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 27 EUROPE RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)
TABLE 28 EUROPE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 29 EUROPE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 30 EUROPE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 31 EUROPE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 32 GERMANY RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 33 GERMANY RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 34 GERMANY RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 35 GERMANY RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 36 FRANCE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 37 FRANCE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 38 FRANCE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 39 FRANCE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 40 U.K. RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 41 U.K. RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 42 U.K. RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 43 U.K. RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 44 ITALY RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 45 ITALY RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 46 ITALY RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 47 ITALY RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 48 SPAIN RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 49 SPAIN RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 50 SPAIN RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 51 SPAIN RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 52 REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 53 REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 54 REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 55 REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 56 EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 57 EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 58 EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 59 EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 60 ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)
TABLE 61 ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 62 ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 63 ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 64 ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 65 JAPAN RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 66 JAPAN RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 67 JAPAN RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 68 JAPAN RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 69 CHINA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 70 CHINA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 71 CHINA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 72 CHINA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 73 INDIA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 74 INDIA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 75 INDIA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 76 INDIA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 77 REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 78 REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 79 REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 80 REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 81 REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 82 REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 83 REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 84 REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 85 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY REGION, 2014-2023 (USD MILLION)
TABLE 86 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 87 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 88 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 90 MIDDLE EAST RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 91 MIDDLE EAST RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 92 MIDDLE EAST RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 93 MIDDLE EAST RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 94 AFRICA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
TABLE 95 AFRICA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
TABLE 96 AFRICA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
TABLE 97 AFRICA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
TABLE 98 ADHERIUM: KEY DEVELOPMENTS
TABLE 99 ASTRAZENECA: PRODUCT OVERVIEW
TABLE 100 ASTRAZENECA: KEY DEVELOPMENTS
TABLE 101 BOEHRINGER INGELHEIM GMBH: PRODUCT OVERVIEW
TABLE 102 BOEHRINGER INGELHEIM GMBH: KEY DEVELOPMENTS
TABLE 103 CHIESI FARMACEUTICI S.P.A: PRODUCT OVERVIEW
TABLE 104 CHIESI FARMACEUTICI S.P.A: KEY DEVELOPMENTS
TABLE 105 GLAXOSMITHKLINE PLC: PRODUCT OVERVIEW
TABLE 106 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS
TABLE 107 PROPELLER HEALTH: PRODUCT/SERVICES OVERVIEW
TABLE 108 PROPELLER HEALTH: KEY DEVELOPMENTS
TABLE 109 TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT FINANCIALS
TABLE 110 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS

FIGURE 1 GLOBAL RESPIRATORY INHALER MARKET SHARE, BY TYPE, 2016 (%)
FIGURE 2 GLOBAL RESPIRATORY INHALER MARKET SHARE, BY PRODUCT, 2016 (%)
FIGURE 3 GLOBAL RESPIRATORY INHALER MARKET SHARE, BY APPLICATION, 2016 (%)
FIGURE 4 GLOBAL RESPIRATORY INHALER MARKET SHARE, BY END USER, 2016 (%)
FIGURE 5 GLOBAL RESPIRATORY INHALER MARKET SHARE, BY REGION, 2016 (%)
FIGURE 6 MARKET STRUCTURE OF GLOBAL RESPIRATORY INHALER MARKET
FIGURE 7 RESEARCH PROCESS OF MRFR
FIGURE 8 DROC OF GLOBAL RESPIRATORY INHALERS MARKET
FIGURE 9 PORTERS FIVE FORCES MODEL
FIGURE 10 GLOBAL RESPIRATORY INHALERS MARKET, BY TYPE, 2016 & 2023 (USD MILLION)
FIGURE 11 GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCT, 2016 & 2023
FIGURE 12 GLOBAL RESPIRATORY INHALERS MARKET, BY APPLICATION, 2016 & 2023 (USD MILLION)
FIGURE 13 GLOBAL RESPIRATORY INHALERS MARKET, BY END USER, 2016 & 2023 (USD MILLION)
FIGURE 14 GLOBAL RESPIRATORY INHALERS MARKET SHARE, BY REGION, 2016 (%)
FIGURE 15 NORTH AMERICA RESPIRATORY INHALERS MARKET SHARE, BY COUNTRY, 2016 (%)
FIGURE 16 EUROPE RESPIRATORY INHALERS MARKET SHARE, BY COUNTRY, 2016 (%)
FIGURE 17 ASIA-PACIFIC RESPIRATORY INHALERS MARKET SHARE, BY COUNTRY, 2016 (%)
FIGURE 18 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY REGION, 2016 (%)
FIGURE 19 GLOBAL RESPIRATORY INHALER MARKET: COMPANY SHARE ANALYSIS, 2016 (%)
FIGURE 20 ADHERIUM: SWOT ANALYSIS
FIGURE 21 ASTRAZENECA: RECENT FINANCIAL
FIGURE 22 ASTRAZENECA: GEOGRAPHICAL MIX, 2016 (%)
FIGURE 23 ASTRAZENECA: OPERATING SEGMENTS, 2016 (%)
FIGURE 24 ASTRAZENECA: RESPIRATORY SEGMENT MIX, 2016 (%)
FIGURE 25 ASTRAZENECA: SWOT ANALYSIS
FIGURE 26 BOEHRINGER INGELHEIM GMBH: RECENT FINANCIALS
FIGURE 27 BOEHRINGER INGELHEIM GMBH: GEOGRAPHICAL MIX, 2016 (%)
FIGURE 28 BOEHRINGER INGELHEIM GMBH: OPERATING SEGMENTS, 2016 (%)
FIGURE 29 BOEHRINGER INGELHEIM GMBH: SWOT ANALYSIS
FIGURE 30 CHIESI FARMACEUTICI S.P.A: RECENT FINANCIALS
FIGURE 31 CHIESI FARMACEUTICI S.P.A: GEOGRAPHICAL MIX, 2015 (%)
FIGURE 32 CHIESI FARMACEUTICI S.P.A: RESPIRATORY SEGMENT MIX, 2016 (USD MILLION)
FIGURE 33 CHIESI FARMACEUTICI S.P.A: SWOT ANALYSIS
FIGURE 34 GLAXOSMITHKLINE: RECENT FINANCIALS
FIGURE 35 GLAXOSMITHKLINE PLC: GEOGRAPHICAL MIX, 2016 (%)
FIGURE 36 GLAXOSMITHKLINE PLC: OPERATING SEGMENTS, 2016 (%)
FIGURE 37 GLAXOSMITHKLINE PLC: PHARMACEUTICAL BUSINESS MIX, 2016 (%)
FIGURE 38 GLAXOSMITHKLINE: SWOT ANALYSIS
FIGURE 39 PROPELLER HEALTH: SWOT ANALYSIS
FIGURE 40 TEVA PHARMACEUTICAL INDUSTRIES LTD: GEOGRAPHICAL MIX, 2016 (%)
FIGURE 41 TEVA PHARMACEUTICAL INDUSTRIES LTD: OPERATING SEGMENTS, 2016 (%)
FIGURE 42 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS